For pharma, volatility and value are two sides of the same coin
But beyond output consistency, a diversified manufacturing base is important: EDB
Singapore
FOR the four months to July, Singapore's export-oriented drug industry notched up double-digit yearly growth, while July exports surged a stunning 109 per cent - yet industry players are hard put to forecast a consistent trajectory.
Rather, the prognosis for the notoriously volatile sector is for it to hold "steady".
TRENDING NOW
Changes to EV incentives, uncertainty over COE framework drive Category A premium to a new high in ‘re-run of 2025 mania’
Employers want AI-fluent employees. Hiring them is the challenge
What makes a good job? Feeling that you matter
Targeted credit relief: Vietnam steers funding to Vingroup, Sun Group, Masterise megaprojects